- 昭衍新药 (603127)- 净利润 之 形成过程

利润分析步骤二:分析 营业利润 到 净利润 的变化

营业利润

-0.7亿    ,0.9,1.3,2.1,3.6,6.4,12.3,5.1,-0.7
了解明细
营业外收入

0.0亿    ,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0
了解明细
营业外支出

0.0亿    ,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
了解明细
利润总额

-0.7亿    ,0.9,1.3,2.1,3.6,6.4,12.4,5.1,-0.7
了解明细


净利润

-0.7亿    ,0.8,1.1,1.8,3.1,5.6,10.7,3.9,-0.7
了解明细
所得税

0.0亿    ,0.2,0.2,0.3,0.5,0.9,1.7,1.2,0.0
了解明细


归母净利润

-0.7亿    ,0.8,1.1,1.8,3.2,5.6,10.7,4.0,-0.7
了解明细
少数股东损益

-0.0亿    ,-0.0,-0.0,-0.0,-0.0,-0.0,-0.0,-0.1,-0.0
了解明细
持续经营净利润

-0.7亿    ,0.8,1.1,1.8,3.1,5.6,10.7,3.9,-0.7
了解明细
终止经营净利润

0亿    ,0,0,0,0,0,0,0,0
了解明细


归母其他综合收益

-0.0亿    ,-0.0,0.0,-0.0,0.3,-0.0,0.7,0.0,-0.0
了解明细
归少数股东其他综合收益

0亿    ,0,0,0,0,0,0,0,0
了解明细


归母综合收益总额

-0.8亿    ,0.8,1.1,1.8,3.4,5.5,11.4,4.0,-0.8
了解明细
归少数股东综合收益总额

-0.0亿    ,-0.0,-0.0,-0.0,-0.0,-0.0,-0.0,-0.1,-0.0
了解明细